SCHEMBL13216466

SCHEMBL13216466

CC12CCCC1C1CCC3=CC(=O)CCC3C1CC2

nearest known ligand 0.66

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 2/20 0.66
▸ SERPINA6 P08185 2/20 0.62
▸ ALDH1A1 P00352 2/20 0.62
▸ SHBG P04278 2/20 0.62
▸ SLC22A1 O15245 1/20 0.62
▸ THRB P10828 1/20 0.62
▸ PGR P06401 4/20 0.56
▸ LMNA P02545 2/20 0.56
▸ CYP3A4 P08684 2/20 0.56
▸ ABCB11 O95342 2/20 0.56
▸ TSHR P16473 1/20 0.56
▸ CYP2C19 P33261 1/20 0.56
▸ HIF1A Q16665 1/20 0.56
▸ ESR1 P03372 1/20 0.56
▸ NR3C1 P04150 1/20 0.56
▸ ADRA2A P08913 1/20 0.56
▸ SLC6A4 P31645 1/20 0.56
▸ AR P10275 3/20 0.55
▸ NR3C2 P08235 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL922877 1.00 CYP19A1 (0.66) CYP19A1SERPINA6ALDH1A1SHBGSLC22A1
SCHEMBL19608861 1.00 CYP19A1 (0.66) CYP19A1SERPINA6ALDH1A1SHBGSLC22A1
SCHEMBL26425075 1.00 CYP19A1 (0.66) CYP19A1SERPINA6ALDH1A1SHBGSLC22A1
SCHEMBL11977689 1.00 CYP19A1 (0.66) CYP19A1SERPINA6ALDH1A1SHBGSLC22A1
Cyclohexane Propionic Acid SCHEMBL27589911 0.84 SERPINA6 (0.49) CYP19A1SERPINA6ALDH1A1SHBGSLC22A1
SCHEMBL9116613 0.82 CYP19A1 (0.60) CYP19A1SERPINA6ALDH1A1SHBGSLC22A1
SCHEMBL11795958 0.81 AR (0.64) CYP19A1SERPINA6ALDH1A1SHBGSLC22A1
SCHEMBL9948814 0.81 CYP19A1 (0.44) CYP19A1SERPINA6ALDH1A1SHBGSLC22A1
SCHEMBL9948623 0.81 CYP19A1 (0.44) CYP19A1SERPINA6ALDH1A1SHBGSLC22A1
SCHEMBL24102654 0.80 PGR (0.56) CYP19A1SERPINA6ALDH1A1SHBGSLC22A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4164743-A2 MONOMERIC AND OLIGOMERIC COMPOUND EMBODIMENTS AS CONTRACEPTIVES AND THERAPIES AND METHODS OF MAKING AND USING THE SAME The United States of America, as represented by The Secretary, Department of Health and Human Services (US) 2023-04-19 — — EP disclosed
US-7772218-B2 Synthesis of anti-estrogenic and other therapeutic steroids from 21-hydroxy-19-norpregna-4-en-3-one SRI INTERNATIONAL (US) 2010-08-10 — — US disclosed
Send feedback